Mode
Text Size
Log in / Sign up
N/A Completed N=107 Randomized Health Services Research

Effectiveness and Cost-effectiveness of iCBT-I in Clinical Settings

Source: ClinicalTrials.gov NCT04300218 ↗
Enrolled (actual)
107
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcomePrimary: Insomnia Severity Index (ISI) — 10.0; 13.5; 11.3; 13.1 units on a scale

Summary

The proposed parallel-group randomized controlled trial add-on superiority of the iCBT-I program with CAU as a control condition will let us investigate the effectiveness and cost-effectiveness of iCBT-I. Analysis of baseline characteristics of the participants aims to find predictors of outcome

Outcome Measures

OutcomeResultp-value
PRIMARY
Insomnia Severity Index (ISI)
10.0; 13.5; 11.3; 13.1
SECONDARY
Sleep Onset Latency (SOL),
28.2; 39.2; 33.3; 42.5
SECONDARY
Total Sleep Time (TST)
6.9; 7.0; 7.3; 7.0
SECONDARY
Sleep Efficiency (SE)
84.5; 81.9; 83.8; 80.2
SECONDARY
Wake After Sleep Onset (WASO)
19.0; 28.0; 28.8; 29.3
SECONDARY
Fatigue Severity Scale (FSS)
35.1; 40.6; 33.3; 38.3
SECONDARY
Short-form Survey (SF-12 Version 1.0)
34.7; 33.1; 33.7; 32.8
SECONDARY
Epworth Sleepiness Scale (ESS)
4.4; 4.1; 3.9; 4.0
SECONDARY
Beck Anxiety Inventory (BAI)
7.0; 9.8; 8.3; 9.3
SECONDARY
Beck Depression Inventory (BDI-II)
6.7; 10.2; 8.0; 10.3
SECONDARY
Sleep Hygiene Index (SHI)
51.9; 49.8; 27.7; 28.5
SECONDARY
Sleep Locus of Control Questionnaire (SLC)
38.5; 38.6; 39.8; 40.1
SECONDARY
Dysfunctional Beliefs and Attitudes About Sleep Scale (DBAS)
75.3; 95.8; 76.1; 99.3
SECONDARY
Anxiousness Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
2.43; 2.62
SECONDARY
Trimbos Questionnaire for Costs Associated With Psychiatric Illness (TiC-P) Health Care Consumption
16500; 4896; 6263; 5959
SECONDARY
Trimbos Questionnaire for Costs Associated With Psychiatric Illness (TiC-P) Short Form- Health and Labour Questionnaire (SF-HLQ)
2449; 7238; 1196; 2853
SECONDARY
Success Expectancy
6.3; 6.2
SECONDARY
User Satisfaction
3.7; 5.0
SECONDARY
System Usability Scale (SUS)
32.8; 10
SECONDARY
Number of Completed Modules
6.54; 4.93
SECONDARY
Total Time Spent on the iCBT-I Website
SECONDARY
Time Spent on Each Module
SECONDARY
Number of Completed Sleep Diaries
6.54; 4.93
SECONDARY
Usage of the Support
9.44; 7.74
SECONDARY
Attention Seeking From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
2.24; 2.04
SECONDARY
Callousness From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.26; 1.33
SECONDARY
Deceitfulness From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.49; 1.57
SECONDARY
Depressivity From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.23; 1.43
SECONDARY
Distractability From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
2.10; 2.27
SECONDARY
Eccentricity From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.67; 1.62
SECONDARY
Emotional Lability From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.70; 1.79
SECONDARY
Grandiosity From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.65; 1.56
SECONDARY
Hostility From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.75; 2.01
SECONDARY
Impulsivity From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.69; 1.63
SECONDARY
Intimacy Avoidance From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.70; 1.82
SECONDARY
Irresponsibility From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.34; 1.35
SECONDARY
Manipulativeness From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.65; 1.65
SECONDARY
Perceptual Dysregulation From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.16; 1.14
SECONDARY
Perseveration From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
2.08; 2.24
SECONDARY
Restricted Affectivity From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.91; 2.13
SECONDARY
Rigid Perfectionism From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
2.21; 2.28
SECONDARY
Risk Taking From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.50; 1.52
SECONDARY
Separation Insecurity From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
2.24; 2.49
SECONDARY
Submissiveness From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
2.17; 2.16
SECONDARY
Suspiciousness From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.58; 1.57
SECONDARY
Unusual Beliefs Experience From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.24; 1.13
SECONDARY
Withdrawal From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.81; 2.08
SECONDARY
Anhedonia From Personality Inventory for DSM-5 Faceted Brief Form (PID-5-FBF) Predictive Effect on ISI Improvement
1.69; 1.89

Eligibility Criteria

Inclusion Criteria

  • Sleep disorder matching chronic insomnia criteria (International Classification of Sleep Disorders-3) - assessed by clinical judgement
  • Ability to follow the procedures of the study, fluent Russian language, Good access to internet - assessed by self-report

Exclusion Criteria

  • Presence of dementia (identified by history or a score 28 ) and the Beck Anxiety Inventory (BAI; score > 26) - assessed by the questionnaires
  • History of severe psychiatric comorbidities other than anxiety and depression (bipolar disorders, psychotic disorders) or substance use disorder - assessed by self-report and clinical history
  • Untreated severe obstructive sleep apnea syndrome (apnea-hypopnea index (AHI) > 15), restless legs syndrome (movement index with arousal > 15 per hour) or other sleep disorders affecting night sleep - assessed by clinical judgement and clinical history
  • pregnancy, lactation - assessed by self-report
  • having a serious somatic condition or brain disorders (stroke, Parkinson's disease…) preventing further participation - assessed by self-report
  • Having high suicidality risk - assessed by clinical judgement, high total BDI-II score (> 29) or score >1 on a BDI-II of suicidality subscale
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04300218). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search